Evidence map›Paper›PMID 35299989›Full record

Article3 Biotech2022

Isomaltooligosaccharides utilization and genomic characterization of human infant anti-inflammatory

Shikha Sharma, Shashank Singh, Vasvi Chaudhary, Shrikant Mantri, Atul Chander, Ruchika Maurya, Sivasubhramanian Rajarammohan, Ravindra Pal Singh, Praveen Rishi, Mahendra Bishnoi and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Shikha Sharma *Healthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.
Shashank Singh *Healthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.
Vasvi ChaudharyDepartment of Microbial Interactions, IMIT/ZMBP, University of Tuebingen, Tuebingen, Germany.
Shrikant MantriAgri-Biotechnology Division, National Agri-Food Biotechnology Institute, S.A.S. Nagar, 140306 India.
Atul ChanderHealthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.
Ruchika MauryaHealthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.
Sivasubhramanian RajarammohanAgri-Biotechnology Division, National Agri-Food Biotechnology Institute, S.A.S. Nagar, 140306 India.
Ravindra Pal SinghHealthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.
Praveen RishiDepartment of Microbiology, Panjab University, Chandigarh, 160014 India.
Mahendra BishnoiHealthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.
Sanjay Kumar BhadadaDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012 India.
Kanthi Kiran KondepudiHealthy Gut Research Group, Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), S.A.S. Nagar, Punjab 140306 India.ORCID 0000-0001-8036-7555
National Agri-Food Biotechnology Institute · INRegional Centre for Biotechnology · INPanjab University · INPost Graduate Institute of Medical Education and Research · INUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was carried out to understand the probiotic features, ability to utilize non-digestible carbohydrates and comparative genomics of anti-inflammatory Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-022-03141-2.

Indexed as

Anti-inflammatory activityBifidobacteriumMucin bindingPrebioticsShort chain fatty acids

Identifiers

PMID35299989
PMCPMC8901852
OpenAlexW4220793812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.